CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

View/ Open
Author
Chen, Zhangguo
Chen, Lanfen
Olszak, Torsten
Zeissig, Sebastian
Kuo, Timothy T.
Mandelboim, Ofer
Beauchemin, Nicole
Lanier, Lewis L.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1084/jem.20102575Metadata
Show full item recordCitation
Chen, Zhangguo, Lanfen Chen, Kristi Baker, Torsten Olszak, Sebastian Zeissig, Yu-Hwa Huang, Timothy T. Kuo, Ofer Mandelboim, Nicole Beauchemin, Lewis L. Lanier, and Richard S. Blumberg. 2011. CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells. The Journal of Experimental Medicine 208(13): 2633-2640.Abstract
Although carcinoembryonic antigen (CEA)–related cell adhesion molecule 1 (CEACAM1)has been viewed as a tumor suppressor, increasing clinical evidence shows that high levels of CEACAM1 expression on tumors correlates with poor prognosis and high risk of metastasis. Here, we examined the consequences of CEACAM1 expression on tumor cells. We show that tumor cell–associated CEACAM1 causes intracellular retention of various NKG2D ligands in mouse and human tumor cells. CEACAM1-silenced tumor cells expressed more cell surface NKG2D ligands and exhibited greater sensitivity to natural killer cell–mediated cytolysis in vitro and rejection in vivo. Our studies reveal a novel mechanism through which CEACAM1-bearing tumor cells may escape immune-surveillance.
Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244030/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10445598
Collections
- HMS Scholarly Articles [18278]
Contact administrator regarding this item (to report mistakes or request changes)